X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

BREAST CANCER RESEARCH AND TREATMENT

期刊標題檢索 BREAST CANCER R 最新評論: Do you have Pure Draft Beer? (2024-05-06)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[BREAST CANCER RESEARCH AND TREATMENT]您好,您是該頁面的第 53374 位訪客。

期刊簡介
期刊名稱BREAST CANCER RESEARCH AND TREATMENT BREAST CANCER RESEARCH AND TREATMENT
LetPub Score
7.7
50 ratings
Rate

Reputation
8.7

Influence
6.5

Speed
9.7

期刊簡稱BREAST CANCER RES TR
ISSN0167-6806
E-ISSN1573-7217
h-index139
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.801.2671.019
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q2103 / 404
Category: Medicine
Subcategory: Cancer Research
Q290 / 230

自引率 (2023-2024)6.70%自引率趨勢
掲載範囲
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.
官方網站https://www.springer.com/10549
在線稿件提交https://www.editorialmanager.com/brea
開放訪問No
出版商Springer US
主題領域医学
出版國/地區UNITED STATES
發行頻率月2回刊行
創刊年1981
每年文章數328每年文章數趨勢
黃金OA百分比31.77%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ2142/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0167-6806%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 25%
參考鏈接
相關期刊 【BREAST CANCER RESEARCH AND TREATMENT】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS326296
    CANCER RESEARCH310967
    BMC CANCER242828
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH197878
    INTERNATIONAL JOURNAL OF CANCER188275
    Asian Pacific Journal of Cancer Prevention184161
    CLINICAL CANCER RESEARCH180957
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY171658
    ONCOLOGY REPORTS171241
    CA-A CANCER JOURNAL FOR CLINICIANS163262
  •  

    BREAST CANCER RESEARCH AND TREATMENT BREAST CANCER RESEARCH AND TREATMENT
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [BREAST CANCER RESEARCH AND TREATMENT] 的評論撰寫評論
作者: 八卦晓桐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-06 19:47:35 評論於
Do you have Pure Draft Beer?
(0) 讚! | 八卦晓桐

作者: 长安亦凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-28 18:18:49 評論於
Review Speed: 3.0
Experience Sharing: Submitted on January 8th, received comments from two reviewers on April 24th, asking for revisions. They did not specify whether it was major or minor revisions, and the deadline for revisions is 14 days. According to the comments, experimental data needs to be added, but 14 days is not enough. How long is everyone's usual deadline for revisions?
(0) 讚! | 长安亦凝

作者: 长拳巍昂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-10 21:12:00 評論於
Received reviewer comments 53 days after submission. When submitting the revised manuscript, are the other information options default to the information provided during the first submission? I accidentally submitted without carefully checking the details the second time. Feeling a little nervous now
(0) 讚! | 长拳巍昂

作者: 长安亦凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-26 12:22:49 評論於
I check daily and after one month of submission, it showed that two reviewers were invited. It has been 79 days since I submitted my paper
(0) 讚! | 长安亦凝

作者: 长拳巍昂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-19 17:40:45 評論於
Where can I see the invitations to and reviews of the peers? It has been 43 days since the peer review, should I send an email to inquire?
(0) 讚! | 长拳巍昂

作者: 伏象庚子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-30 10:56:03 評論於
Research focus: Tumor; breast cancer
Experience sharing: Your submission has passed the technical checks and is now in peer review. It has been more than half a month since submission, and it has been in this state all along. What does peer review mean? It's not under review
(0) 讚! | 伏象庚子

作者: 长安亦凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-28 18:22:15 評論於
Invited 4 reviewers, why so many reviewers? Have you ever encountered this?
(0) 讚! | 长安亦凝

作者: 长安亦凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-26 20:37:59 評論於
After half a month of submission, we invited 2 reviewers and sent it for external review
(0) 讚! | 长安亦凝

作者: 长安亦凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 12:23:12 評論於
I submitted it on January 8th, and now it's under peer review. I see some changes in the timeline, showing that the editor was appointed on January 19th
(0) 讚! | 长安亦凝

作者: 香风夜绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-04 18:23:27 評論於
The senior is very patient
(0) 讚! | 香风夜绿

作者: 长安亦凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-31 16:19:27 評論於
Research focus: tumor genetics
Experience sharing: The submission process is different from a few years ago. It seems that there is now a technical review before submission. I just submitted, but I haven't seen it in my account yet. I did receive an email. Has anyone had a similar experience?
(0) 讚! | 长安亦凝

作者: 书生永寿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-06 20:31:47 評論於
I am almost UR two months, bro, any progress on your end?
(0) 讚! | 书生永寿

作者: 晨硕酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-15 14:02:30 評論於
How long have you been waiting for your editor assignment pending?
(0) 讚! | 晨硕酱大魔王

作者: 书生永寿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-13 22:02:04 評論於
I'm the same, updating the time for reminders doesn't change the status either
(0) 讚! | 书生永寿

作者: 金顶俊健


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-08 17:18:55 評論於
It has been three months since we last met. How about you?
(0) 讚! | 金顶俊健

作者: 金顶俊健


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-08 10:51:02 評論於
It's been three months since we last met. How about you?
(0) 讚! | 金顶俊健

作者: 书生永寿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-20 12:28:20 評論於
Brother, how are you doing?
(0) 讚! | 书生永寿

作者: 书生永寿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-13 12:41:06 評論於
I laugh every day ?
(0) 讚! | 书生永寿

作者: 金顶俊健


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-12 12:07:32 評論於
I feel the same way, what's going on? Let's update each other every month
(0) 讚! | 金顶俊健

作者: 书生永寿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-02 21:19:53 評論於
Focused research direction: SNP; Tumor experience sharing: Why do we update UR's time every day?
(0) 讚! | 书生永寿

作者: 千花喜春


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-11 17:46:29 評論於
Do you accept pure life insurance?
(0) 讚! | 千花喜春

作者: Janet Sonmerfield


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-02 15:40:04 評論於
When is the decision made whether to use OA, is it made at the time of submission?
(0) 讚! | Janet Sonmerfield

作者: Janet Sonmerfield


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-02 13:47:55 評論於
When do we decide whether to go OA, during the submission process?
(0) 讚! | Janet Sonmerfield

作者: 凤凰院亭晚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-27 08:43:14 評論於
This is too disgusting
(0) 讚! | 凤凰院亭晚

作者: 宗室曼玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-24 15:19:28 評論於
More than seven months have passed
(0) 讚! | 宗室曼玉

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [BREAST CANCER RESEARCH AND TREATMENT] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*